文献速递胃肠外科围术期管理与 ERAS

结直肠癌卵巢转移患者的临床病理特征及术后预后模型构建

[Clinicopathologic characteristics of patients with ovarian metastases from colorectal cancer and construction of postoperative prognostic models].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2025-01-01

该回顾性病例系列研究纳入81例接受卵巢转移瘤根治性切除的结直肠癌卵巢转移患者,构建基于阳性淋巴结比率、转移瘤最大径及腹膜转移或腹水的风险评分系统,将患者分为高危组和低危组,模型预测效能良好且内部验证稳定。

要点

  • 结直肠癌卵巢转移根治术时应考虑双侧卵巢切除以降低对侧复发风险。
  • 转移瘤最大径≥6 cm、阳性淋巴结比率≥0.3及腹膜转移或腹水提示预后较差。
  • 基于上述因素的风险评分系统可对患者进行预后风险分层。

核心结论

  • 对结直肠癌卵巢转移患者行根治性手术时,应切除双侧卵巢以尽可能降低术后复发风险。
  • 卵巢转移瘤最大径≥6 cm、阳性淋巴结比率≥0.3及腹膜转移或腹水阳性的患者预后较差。
  • 基于上述因素构建的预后评分系统可对患者进行预后风险分层。

研究设计与样本

  • 回顾性病例系列研究,纳入2014年1月至2023年12月中国医学科学院肿瘤医院结直肠外科81例接受卵巢转移瘤根治性切除的结直肠癌卵巢转移女性患者。
  • 患者年龄M(IQR)49(13)岁(范围22~79岁),原发灶位于结肠60例(74.1%)、直肠21例(25.9%)。
  • 采用单因素和多因素Cox回归分析筛选独立预后因素,构建风险评分系统,并通过5折交叉验证评价模型内部稳定性。

主要发现

  • 81例患者中T4期58例(71.6%)、淋巴结阳性68例(84.0%)、结肠癌60例(74.1%)。
  • 15例(23.4%)术前影像学考虑单侧卵巢转移,双侧卵巢切除后病理确诊为双侧转移;单侧卵巢切除的17例中11例术后出现对侧转移。
  • 多因素Cox回归显示阳性淋巴结比率(HR=3.34,95%CI:1.08~10.34,P=0.037)和转移瘤最大径(HR=2.65,95%CI:1.19~5.88,P=0.017)是总体生存的独立预后因素。
  • 以最佳截断值154分将患者分为高危组19例和低危组62例,高危组中位总体生存27个月、中位无病生存22个月,低危组中位总体生存90个月、中位无病生存未达到(P值均<0.01)。
  • 模型预测1、3、5年总体生存率的AUC分别为0.731(95%CI:0.563~0.899)、0.703(95%CI:0.573~0.833)、0.776(95%CI:0.657~0.894)。

关键数值与推荐

  • 风险评分系统基于卵巢转移瘤最大径≥6 cm、阳性淋巴结比率≥0.3及腹膜转移或伴有腹水三个变量构建。
  • 风险评分最佳截断值为154分,据此分为高危组和低危组。
  • 模型预测1、3、5年无病生存率的AUC分别为0.724(95%CI:0.397~0.993)、0.710(95%CI:0.514~0.906)、0.688(95%CI:0.478~0.898)。

临床怎么用

  • 对结直肠癌卵巢转移患者行根治性手术时,应考虑双侧卵巢切除以降低对侧卵巢转移和复发风险。
  • 术后可依据转移瘤最大径、阳性淋巴结比率及腹膜转移或腹水情况计算风险评分,进行预后风险分层。
  • 高危组患者术后中位总体生存和无病生存较短,可能需加强术后随访和管理。

局限性

  • 本研究为单中心回顾性病例系列研究,样本量81例,结论需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To construct and validate a prognostic prediction model for patients with ovarian metastases from colorectal cancer after radical resection. Methods: A retrospective case series analysis was conducted on the clinical and pathological data of 81 patients with colorectal cancer and ovarian metastases who underwent radical resection for ovarian metastases at the Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, between January 2014 and December 2023. The patients were all female, with an age (M(IQR)) of 49(13) years (range: 22 to 79 years). The primary tumor was located in the colon in 60 cases (74.1%) and in the rectum in 21 cases (25.9%). Univariate and multivariate Cox regression analyses were used to identify independent risk factors affecting prognosis. A risk scoring system was constructed, and patients were assigned to high-risk and low-risk groups based on their risk scores. The predictive performance of the scoring system was assessed, and 5-fold cross-validation was performed to evaluate the model's stability on the internal dataset. Results: Among the 81 patients with ovarian metastases, a high proportion had T4 stage (58 cases, 71.6%), lymph node positivity (68 cases, 84.0%), and colon cancer (60 cases, 74.1%). Preoperative imaging suggested unilateral ovarian metastasis in 15 patients (23.4%), but pathological examination after bilateral oophorectomy confirmed bilateral ovarian metastases. Among the 17 patients who initially underwent unilateral oophorectomy, 11 developed contralateral ovarian metastases at varying times postoperatively. Univariate Cox proportional hazards regression analysis revealed that positive lymph node ratio (HR=2.68,95%CI:1.41 to 5.09,P=0.003), N stage (HR=2.07,95%CI:1.08 to 3.95, P=0.028),maximum diameter of metastatic tumors (HR=2.27,95%CI:1.04 to 4.96, P=0.040),and peritoneal metastasis or ascites at the time of ovarian metastasis (HR=2.04,95%CI:1.02 to 4.08, P=0.043) were significantly associated with overall survival in patients with ovarian metastasis from colorectal cancer. Multivariate regression analysis identified that positive lymph node ratio (HR=3.34,95%CI:1.08 to 10.34, P=0.037) and maximum diameter of metastatic tumors (HR=2.65,95%CI:1.19 to 5.88, P=0.017) were independent prognostic factors for overall survival following radical oophorectomy in patients with ovarian metastasis from colorectal cancer. Based on the regression coefficients from the multivariate analysis for variables (ovarian metastatic tumor diameter ≥6 cm, positive lymph node ratio ≥0.3,and presence of peritoneal metastasis or ascites), a risk scoring system was developed. Using the optimal cutoff value (154 points) for the risk score,patients were divided into high-risk (19 cases) and low-risk (62 cases) groups. Kaplan-Meier survival curves demonstrated that the high-risk group had significantly lower median overall survival (27 months) and median disease-free survival (22 months) compared to the low-risk group (median overall survival 90 months,median disease-free survival not reached; both P<0.01). Receiver operating characteristic curve analysis showed that the area under the curve(AUC) for predicting 1-,3-,and 5-year overall survival was 0.731(95%CI:0.563 to 0.899), 0.703(95%CI:0.573 to 0.833), and 0.776(95%CI: 0.657 to 0.894), respectively. The AUC for predicting 1-,3-, and 5-year disease-free survival was 0.724(95%CI:0.397 to 0.993),0.710(95%CI:0.514 to 0.906),and 0.688(95%CI:0.478 to 0.898),respectively,indicating good performance of the model.The decision curve analysis showed that the model has good clinical net benefit and the results of the 5-fold cross-validation showed that the model demonstrated stability in the internal dataset. Conclusions: When performing radical resection for ovarian metastasis from colorectal cancer,bilateral oophorectomy should be considered to minimize the risk of postoperative recurrence. Patients with ovarian metastasis from colorectal cancer,characterized by a metastatic tumor diameter ≥6 cm,a positive lymph node ratio ≥0.3,and the presence of peritoneal metastasis or ascites, tend to have a poorer prognosis. Based on these findings,a clinical prognostic scoring system for radical resection of ovarian metastasis from colorectal cancer has been developed to stratify patients into different risk groups and may assist in postoperative risk assessment and management. 目的: 构建并验证根治性切除术后结直肠癌卵巢转移患者的预后预测模型。 方法: 本研究为回顾性病例系列研究。回顾性分析2014年1月至2023年12月于中国医学科学院肿瘤医院结直肠外科接受卵巢转移瘤根治性切除的81例结直肠癌卵巢转移患者的临床和病理学资料。患者均为女性,年龄[M(IQR)]49(13)岁(范围:22~79岁)。原发灶位于结肠60例(74.1%),位于直肠21例(25.9%)。采用单因素和多因素Cox回归分析筛选独立预后因素。构建风险评分系统并计算患者的风险评分,将患者分为高危组和低危组,评估风险评分系统的预测效能,并通过5折交叉验证,评价模型在内部数据集中的稳定性。 结果: 81例患者中,T4期58例(71.6%)、淋巴结阳性68例(84.0%)、结肠癌60例(74.1%)。15例(23.4%)患者的术前影像学检查结果考虑为单侧卵巢转移,双侧卵巢切除后病理学检查报告为双侧卵巢转移癌。在单侧卵巢切除的17例患者中,11例在术后不同时间出现了对侧卵巢转移。单因素Cox比例风险回归模型分析结果显示,阳性淋巴结比率(HR=2.68,95%CI:1.41~5.09,P=0.003)、N分期(HR=2.07,95%CI:1.08~3.95,P=0.028)、转移瘤最大径(HR=2.27,95%CI:1.04~4.96,P=0.040)和出现腹膜转移或腹水(HR=2.04,95%CI:1.02~4.08,P=0.043)是结直肠癌卵巢转移患者卵巢根治性切除术后总体生存的预后因素(P值均<0.05)。多因素Cox回归模型分析结果显示,阳性淋巴结比率(HR=3.34,95%CI:1.08~10.34,P=0.037)和转移瘤最大径(HR=2.65,95%CI:1.19~5.88,P=0.017)是结直肠癌卵巢转移患者卵巢根治性切除术后总体生存的独立预后因素。依据多因素回归分析获得变量(卵巢转移瘤最大径≥6 cm、阳性淋巴结比率≥0.3及腹膜转移或伴有腹水)的回归系数,建立风险评分系统,根据风险评分的最佳截断值(154分)作为分界点,将患者分为高危组(19例)和低危组(62例)。Kaplan-Meier生存曲线显示,高危组患者的中位总体生存时间(27个月)和中位无病生存时间(22个月)低于低危组(中位总体生存时间为90个月,中位无病生存时间未达到;P值均<0.01)。受试者工作特征曲线分析结果显示,风险评分系统预测1、3、5年总体生存率的曲线下面积分别为0.731(95%CI:0.563~0.899)、0.703(95%CI:0.573~0.833)、0.776(95%CI:0.657~0.894);1、3、5年无病生存率的曲线下面积分别为0.724(95%CI:0.397~0.993)、0.710(95%CI:0.514~0.906)、0.688(95%CI:0.478~0.898),提示模型的预测效能良好。决策曲线分析结果显示,模型有较好的临床净受益,5折交叉验证结果显示模型在内部数据集中表现稳定。 结论: 对结直肠癌卵巢转移患者行根治性手术时,应切除双侧卵巢以尽可能降低术后复发风险。卵巢转移瘤最大径≥6 cm、阳性淋巴结比率≥0.3及腹膜转移或腹水阳性的结直肠癌卵巢转移患者的预后较差。基于此结果构建的结直肠癌卵巢转移患者根治性切除术的临床预后评分系统,可对患者进行预后风险分层。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang Q, Xiang RS, Lu SB, et al. [Clinicopathologic characteristics of patients with ovarian metastases from colorectal cancer and construction of postoperative prognostic models]. Zhonghua Wai Ke Za Zhi. 2025. PMID: 41216738. doi:10.3760/cma.j.cn112139-20250331-00168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。